KR102287389B1 - Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer - Google Patents
Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer Download PDFInfo
- Publication number
- KR102287389B1 KR102287389B1 KR1020190081667A KR20190081667A KR102287389B1 KR 102287389 B1 KR102287389 B1 KR 102287389B1 KR 1020190081667 A KR1020190081667 A KR 1020190081667A KR 20190081667 A KR20190081667 A KR 20190081667A KR 102287389 B1 KR102287389 B1 KR 102287389B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- extract
- composition
- present
- antibacterial
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 103
- 240000004371 Panax ginseng Species 0.000 title claims abstract description 99
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 6
- 239000000284 extract Substances 0.000 title abstract description 63
- 230000000845 anti-microbial effect Effects 0.000 title description 18
- 241000511582 Actinomyces meyeri Species 0.000 title 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 97
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 97
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 52
- 241001465754 Metazoa Species 0.000 claims abstract description 20
- 239000002537 cosmetic Substances 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- 230000036541 health Effects 0.000 claims abstract description 14
- 239000000469 ethanolic extract Substances 0.000 claims abstract description 12
- 239000012459 cleaning agent Substances 0.000 claims abstract description 11
- 235000013376 functional food Nutrition 0.000 claims abstract description 11
- 239000003599 detergent Substances 0.000 claims abstract description 8
- 241000208340 Araliaceae Species 0.000 claims abstract description 5
- 241000192125 Firmicutes Species 0.000 claims description 9
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 241000186779 Listeria monocytogenes Species 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 3
- 239000000490 cosmetic additive Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 235000019730 animal feed additive Nutrition 0.000 claims description 2
- 239000000654 additive Substances 0.000 abstract description 19
- 235000013305 food Nutrition 0.000 abstract description 19
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 239000000843 powder Substances 0.000 abstract description 8
- 230000000996 additive effect Effects 0.000 abstract description 7
- 239000003826 tablet Substances 0.000 abstract description 4
- 239000006071 cream Substances 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000002378 acidificating effect Effects 0.000 abstract description 2
- 244000144972 livestock Species 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 241000588767 Proteus vulgaris Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 229940007042 proteus vulgaris Drugs 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- -1 maltose and sucrose Chemical compound 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 241000258955 Echinodermata Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002034 butanolic fraction Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 229940107131 ginseng root Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000751182 Staphylococcus epidermidis ATCC 12228 Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003006 anti-agglomeration agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/34635—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Botany (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Agronomy & Crop Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dentistry (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 인삼 꽃봉오리(flower bud of Panax ginseng C. A. Meyer) 추출물을 유효성분으로 함유하는 항균 조성물에 관한 것으로서, 보다 상세하게는, 인삼 꽃봉오리의 에탄올 추출물을 유효성분으로 함유하는 광범위 항균 조성물에 관한 것이다. 본 발명의 광범위 항균 조성물의 유효성분으로서의 인삼 꽃봉오리 추출물은, 본 명세서의 실시예를 통해 증명된 바와 같이, 항균용 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품 또는 동물 사료용 첨가물, 각종 세정제 및 각종 청결제 등의 용도로 사용할 수 있는 뛰어난 효과가 있다. 뿐만 아니라, 본 발명의 인삼 꽃봉오리 추출물은 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 활성의 손실이 나타나지 않아, 액상, 크림, 분말, 환, 정 등의 다양한 형태로 손쉽게 가공될 수 있어 제약 산업, 식품 산업, 축산업, 보건 산업 및 화장품 산업상 매우 유용하게 이용될 수 있다.The present invention relates to an antibacterial composition containing an extract of a flower bud of Panax ginseng CA Meyer as an active ingredient, and more particularly, to a broad-spectrum antibacterial composition containing an ethanol extract of a ginseng bud as an active ingredient. will be. The ginseng bud extract as an active ingredient of the broad-spectrum antibacterial composition of the present invention, as demonstrated through the examples of the present specification, is an antibacterial pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, food, cosmetic or animal feed. It has an excellent effect that it can be used as an additive, various detergents, and various cleaning agents. In addition, the ginseng bud extract of the present invention has excellent thermal stability and no loss of activity even under acidic conditions of pH 2 and plasma, so it can be easily processed into various forms such as liquid, cream, powder, pill, tablet, etc. Therefore, it can be very usefully used in the pharmaceutical industry, food industry, livestock industry, health industry and cosmetics industry.
Description
본 발명은 인삼 꽃봉오리(flower bud of Panax ginseng C. A. Meyer) 추출물을 유효성분으로 함유하는 항균 조성물에 관한 것으로서, 보다 상세하게는, 인삼 꽃봉오리의 에탄올 추출물을 유효성분으로 함유하는 광범위 항균 조성물에 관한 것이다.The present invention relates to an antibacterial composition containing an extract of a flower bud of Panax ginseng CA Meyer as an active ingredient, and more particularly, to a broad-spectrum antibacterial composition containing an ethanol extract of a ginseng bud as an active ingredient. will be.
인류는 병원성 미생물의 침입을 방어하고, 식품 부패 미생물을 제어하기 위하여 다양한 항균제와 방부제를 사용하여 왔다. 그러나, 화학 항균제 및 방부제의 경우, 다양한 세균과 진균에 우수한 항균력을 보이는 반면, 장기간 사용시에는 알러지(allergy)에 의한 발적, 혈관성 부종, 골수 억제, 빈혈, 위염, 퇴행성 뇌질환 등의 많은 부작용이 나타나게 된다. 실제 미국에서는 클로람페니콜(chloramphenicol) 등의 부작용이 심한 항생제 사용을 금지한 바 있다. 따라서, 안전성이 확보되어 있으면서 장기간 사용 경험이 있는 천연물을 이용한 천연 항균제 개발에 관한 다양한 연구가 진행 중에 있다.Humans have used various antibacterial agents and preservatives to defend against the invasion of pathogenic microorganisms and to control food spoilage microorganisms. However, in the case of chemical antibacterial agents and antiseptics, they show excellent antibacterial activity against various bacteria and fungi, but when used for a long time, many side effects such as redness due to allergy, angioedema, bone marrow suppression, anemia, gastritis, and degenerative brain disease appear. do. In fact, in the United States, the use of antibiotics with severe side effects, such as chloramphenicol, has been banned. Therefore, various studies on the development of natural antibacterial agents using natural products that have been used for a long time while ensuring safety are in progress.
한편, 미국 질병관리예방센터(U.S. Center for Disease Control and Prevention)에 따르면, 병원 내 혈류 감염이 미국에서 주된 사망 원인 중 하나이다. 또한, 피부 및 연조직을 통한 병원성 세균 및 진균의 감염은 보편적인 의학적 질병으로 인식되어 있으며, 주로 외상 또는 수술에 의하여 유발되는 것으로 이해되고 있다. 많은 병원성 세균 및 진균의 감염은 감염의 중증도에 따라 그 처치 방법이 다르지만, 경구용 항미생물제 및 국소 청결로 성공적인 치료가 가능하다. 그러나, 근원적인 위험 인자(예를 들면, 혈관 혈류 이상, 당뇨) 및/또는 치료하기 어렵거나 다중-내성인 세균 및 진균에 의해 유발된 감염을 갖는 환자에서 흔히 발생하는 보다 심하거나 복잡한 감염은 정맥 내 항미생물제 치료 및 침입성 외과적 조직 제거 등의 조치가 필요할 수도 있다. 실례로, 글라이코펩타이드계 항생물질인 반코마이신은 다중-약물-내성 그람-양성균, 특히 MRSA, 응고효소-음성 스태필로코커스 및 엔테로코커스에 의해 야기된 심한 병원 내 감염에 대해 성공적으로 사용되어왔다. 그러나, 최근 반코마이신에 대해 내성을 갖는 균주의 분리가 증가하고 있음이 보고되고 있으며, 현재의 항생제로는 병원균 중 일부균에 의해 유발된 심한 감염에 대한 치료가 매우 제한되어 있는 것이 사실이다. 따라서, 점차 증가되고 있는 내성균에 대한 보다 효과적인 새로운 항생물질 개발의 필요성이 증가되고 있다.Meanwhile, according to the U.S. Center for Disease Control and Prevention, in-hospital bloodstream infection is one of the leading causes of death in the United States. In addition, infection of pathogenic bacteria and fungi through the skin and soft tissues is recognized as a universal medical disease, and it is understood that it is mainly caused by trauma or surgery. Many pathogenic bacterial and fungal infections have different treatment methods depending on the severity of the infection, but successful treatment is possible with oral antimicrobial agents and topical cleaning. However, more severe or complex infections that commonly occur in patients with underlying risk factors (eg, vascular blood flow abnormalities, diabetes) and/or infections caused by difficult-to-treat or multi-resistant bacteria and fungi include intravenous Measures such as antimicrobial treatment and invasive surgical removal may be necessary. For example, the glycopeptide antibiotic vancomycin has been used successfully against severe nosocomial infections caused by multi-drug-resistant Gram-positive bacteria, particularly MRSA, coagulase-negative Staphylococcus and Enterococcus. However, it has been recently reported that the isolation of strains resistant to vancomycin is increasing, and it is true that current antibiotics are very limited in treating severe infections caused by some of the pathogens. Therefore, the need for the development of new more effective antibiotics against increasingly resistant bacteria is increasing.
한편, 인삼(Panax ginseng C. A. Meyer)은 오갈피나무과(Araliaceae) 인삼속(Panax)에 속하는 다년생 초본류로서, 생김새는 가늘고 긴 원주형이나 방추형으로 2~5개의 곁뿌리가 나 있고, 바깥 면은 엷은 황갈색이며 세로주름과 가는 뿌리 자국이 있다. 근두부에는 줄기의 잔기가 붙어 있던 노두가 있다. 한방에서는 인삼의 뿌리를 주로 약재로 사용하며, 원기를 보하고 신체허약, 권태, 피로, 식욕부진, 구토, 설사에 쓰이며 폐기능을 도우며 진액을 생성하고, 안신작용 및 신기능을 높여 준다고 알려져 있다. 실제로 알려진 약리작용으로는 대뇌피질 흥분과 억제, 평형, 항피로, 항노화, 면역증강, 심장수축, 성선촉진, 고혈당 억제, 단백질 합성 촉진, 항상성 유지, 항암, 해독작용 등이 있으며, 인삼 특유의 냄새가 있으며 맛은 달고 약간 쓰며 성질은 약간 따듯하다. 인삼은 뿌리뿐만 아니라, 잎, 줄기, 열매, 씨를 모두 식용으로 사용 가능하며, 특히 인삼의 잎을 인삼엽(人蔘葉), 노두(蘆頭)를 인삼로(人蔘蘆), 종자를 인삼자(人蔘子)로 부르기도 하며, 이는 모두 한방에서 귀한 약재로 사용되고 있다.On the other hand, ginseng ( Panax ginseng CA Meyer) is a perennial herb belonging to the genus Panax of the Araliaceae family. There are vertical wrinkles and fine root marks. At the root, there is an outcrop to which the residues of the stem are attached. In oriental medicine, the root of ginseng is mainly used as a medicinal material, and it is said to be used for body weakness, malaise, fatigue, anorexia, vomiting, and diarrhea. In fact, known pharmacological actions include cerebral cortex excitation and inhibition, balance, anti-fatigue, anti-aging, immune enhancement, heart contraction, gonad stimulation, hyperglycemia suppression, protein synthesis promotion, homeostasis maintenance, anticancer, detoxification, etc. It has an odour, the taste is sweet and slightly bitter, and the nature is slightly warm. In addition to the root, ginseng leaves, stems, fruits and seeds are all edible. In particular, the leaves of ginseng are used as ginseng leaves, the outdus are used as ginseng, and the seeds are used as ginseng. It is also called ja (人蔘子), and all of them are used as precious medicinals in oriental medicine.
인삼은 지하부에 대한 연구가 집중적으로 이루어져 있으나, 인삼 꽃봉오리에 대한 연구는 매우 미미한 상태이다. 국내에서 인삼은 여름에 1개의 꽃자루가 생성되고, 그 끝에 4~40개의 연한 녹색의 작은꽃이 산형꽃차례에 달리며, 통상 꽃은 3~4년생부터 피기 시작하여 5월 중순에 개화한다. 인삼꽃은 별도의 용도없이 폐기되는 상황이며, 인삼뿌리보다 경제적이며 공급면에서 안정적이며, 경제적으로 유리하다. 또한, 인삼근보다 인삼엽 및 인삼꽃에서 사포닌 함량이 더욱 높은 것으로 알려져 있다. 현재까지 인삼꽃 및 꽃봉오리(인삼꽃이 개화하기 직전, 꽃눈이 상당이 발달하여 개화가 가까워진 상태의 아직 피지 않은 꽃)와 관련된 연구로는 인삼꽃의 향기성분 분석(우창식, 2009. 아주대학교 석사논문), 인삼 부위별 추출물의 피부개선효과(도희진, 2013, 서경대학교 석사논문), 발효 인삼꽃 추출물의 경구 투여가 마우스 사이토카인 IL-6, TNF-α의 생성에 미치는 영향(정수지 외, 2014. 한국식품영양학회지 27: 43-49) 및 발효 미생물에 따른 인삼꽃의 항산화 활성(김경희 외, 2013. 한국식품영양과학회지 42: 663-669)등이 알려져 있으며 대부분이 인삼 꽃의 항산화 활성에 대한 보고이다. Although research on the underground part of ginseng is intensively conducted, research on ginseng flower buds is very insignificant. In Korea, 1 peduncle is produced in ginseng in summer, and 4 to 40 light green small flowers hang on the umbel at the end, and flowers usually start to bloom from 3 to 4 years old and bloom in mid-May. Ginseng flowers are discarded without a separate use, and are more economical than ginseng roots, more stable in terms of supply, and economically advantageous. In addition, it is known that saponin content is higher in ginseng leaves and ginseng flowers than in ginseng root. So far, studies related to ginseng flowers and flower buds (flowers that have not yet bloomed, just before the ginseng flower blooms, the flower buds have developed considerably and are close to flowering), include analysis of the fragrance component of ginseng flowers (Chang-Sik Woo, 2009. Ajou University). The effect of oral administration of fermented ginseng flower extract on the production of mouse cytokines IL-6 and TNF-α (Jeong Jung et al.) , 2014. Journal of the Korean Society for Food and Nutrition 27: 43-49) and antioxidant activity of ginseng flowers according to fermenting microorganisms (Kyung-Hee Kim et al., 2013. Journal of Food and Nutrition Sciences 42: 663-669), most of which are antioxidants of ginseng flowers. report on activity.
인삼 꽃봉오리와 관련된 특허로는 대한민국 등록특허 제10-1707522호에 [인삼 꽃 추출물을 함유하는 피부 외용제 조성물], 제10-1784992호에 [인삼 꽃 파우더 및 그 제조방법, 및 이를 함유하는 화장료 조성물], 제10-1656710호에 [활성물질이 증진된 인삼 꽃 복합추출물의 제조방법, 및 이로부터 제조된 기능성 화장료 조성물], 제10-1944039호에 [인삼꽃을 이용한 동물 사료용 조성물], 제10-0017300호에 [인삼의 지상 부추출물을 안정화시켜 첨가한 샴푸 및 린스 조성물], 제10-1601022호에 [인삼꽃 정유를 함유하는 피부용 외용제 조성물], 제10-1438368호에 [인삼꽃의 향취를 재현한 향료 조성물], 제10-1663946호에 [인삼꽃 흑효모 발효를 통한 진세노사이드 Rg3 강화 및 이를 유효성분으로 함유하는 화장료 조성물] 등 화장품과 관련된 등록특허가 대부분이며, 제10-1944039호에 [인삼꽃을 이용한 동물 사료용 조성물], 제10-0894029호이 [인삼 꽃을 원료로 하는 당뇨의 예방을 위한 약학 조성물 및 치료를 위한 약학 조성물], 제10-1016996호에 [진세노사이드를 함유하는 심혈관계 질환의 예방 및 치료용 조성물], 제10-0004149호에 [인삼 꽃봉오리차의 제조방법]도 개시되어 있다. 또한, 대한민국 공개특허 제10-2018-0088226호에 [진세노사이드 함량이 증진된 인삼꽃 추출물을 유효성분으로 포함하는 조성물] 및 제10-2013-0050568호에 [자극완화 및 미백능이 있는 인삼꽃 발효물의 제조방법] 등이 공개되어 있다. 그러나, 현재까지 다양한 그람 양성균과 프로테우스 불가리스(Proteus vulgaris) 등의 알러지성 식중독과 관련된 그람 음성균에 항균 활성을 나타내는 인삼 꽃봉오리 추출물에 대해서는 알려진 바 없다. As patents related to ginseng buds, Korean Patent Registration No. 10-1707522 [composition for external application for skin containing ginseng flower extract] and [ginseng flower powder and manufacturing method thereof, and cosmetic composition containing the same] in No. 10-1784992 ], [Method for producing complex extract of ginseng flower with enhanced active substances, and functional cosmetic composition prepared therefrom] in No. 10-1656710, [Composition for animal feed using ginseng flowers] in No. 10-1944039, No. 10 [Shampoo and rinse composition added by stabilizing ground extract of ginseng] in No. -0017300, [Composition for external application containing ginseng flower essential oil] in No. 10-1601022, [Scent of ginseng flower] in No. 10-1438368 Most of the registered patents related to cosmetics, such as a perfume composition that reproduces [Composition for animal feed using ginseng flower], No. 10-0894029 [Pharmaceutical composition for the prevention and treatment of diabetes using ginseng flower as a raw material], No. 10-1016996 [Ginsenoside A composition for the prevention and treatment of cardiovascular diseases containing a composition for the prevention and treatment of cardiovascular diseases] and [Method for producing ginseng bud tea] are also disclosed in No. 10-0004149. In addition, in Korean Patent Laid-Open No. 10-2018-0088226 [Composition containing ginseng flower extract with enhanced ginsenoside content as an active ingredient] and [Ginseng flower with irritation relief and whitening ability] in No. 10-2013-0050568 Method for producing a fermented product] and the like are disclosed. However, there is no known ginseng bud extract that exhibits antibacterial activity against various Gram-positive bacteria and Gram-negative bacteria related to allergic food poisoning, such as Proteus vulgaris.
본 발명은 상기와 같은 종래 기술의 문제점을 해결하기 위하여 안출된 것으로서, 본 발명에서 해결하고자 하는 과제는 인삼 꽃봉오리 추출물을 유효성분으로 함유하는 광범위 항균 조성물을 제공하고자 하는 것이다.The present invention has been devised to solve the problems of the prior art as described above, and an object to be solved in the present invention is to provide a broad-spectrum antibacterial composition containing a ginseng bud extract as an active ingredient.
상기와 같은 과제를 해결하기 위하여, 본 발명은 인삼 꽃봉오리(Flower bud of Panax ginseng C. A. Meyer) 추출물을 유효성분으로 함유하는 항균 조성물을 제공한다.In order to solve the above problems, the present invention provides an antibacterial composition containing an extract of ginseng flower buds (Flower bud of Panax ginseng CA Meyer) as an active ingredient.
상기 인삼 꽃봉오리 추출물은 인삼 꽃봉오리의 에탄올 추출물인 것이 바람직하다.The ginseng bud extract is preferably an ethanol extract of the ginseng bud.
상기 항균 조성물은 그람 양성 세균(Gram-positive bacteria)에 대한 항균 활성을 갖는 것이 바람직하다.The antimicrobial composition preferably has antimicrobial activity against Gram-positive bacteria.
상기 항균 조성물은 프로테우스 불가리스(Proteus vulgaris)에 대한 항균 활성을 갖는 것이 바람직하다.The antibacterial composition preferably has antibacterial activity against Proteus vulgaris.
상기 항균 조성물은 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품 첨가물, 화장품 첨가물, 동물 사료용 첨가물, 세정제 및 청결제로 이루어지는 군으로부터 선택되는 것이 바람직하다.The antimicrobial composition is preferably selected from the group consisting of pharmaceutical compositions, health functional foods, cosmetic compositions, animal feed compositions, food additives, cosmetic additives, animal feed additives, detergents and cleaners.
본 발명의 광범위 항균 조성물의 유효성분으로서의 인삼 꽃봉오리 추출물은, 본 명세서의 실시예를 통해 증명된 바와 같이, 항균용 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품 또는 동물 사료용 첨가물, 각종 세정제 및 각종 청결제 등의 용도로 사용할 수 있는 뛰어난 효과가 있다. 뿐만 아니라, 본 발명의 인삼 꽃봉오리 추출물은 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 활성의 손실이 나타나지 않아, 액상, 크림, 분말, 환, 정 등의 다양한 형태로 손쉽게 가공될 수 있어 제약 산업, 식품 산업, 축산업, 보건 산업 및 화장품 산업상 매우 유용하게 이용될 수 있다.The ginseng bud extract as an active ingredient of the broad-spectrum antibacterial composition of the present invention, as demonstrated through the examples of the present specification, is an antibacterial pharmaceutical composition, a health functional food, a cosmetic composition, an animal feed composition, food, cosmetic or animal feed It has an excellent effect that it can be used as an additive, various cleaning agents, and various cleaning agents. In addition, the ginseng bud extract of the present invention has excellent thermal stability and no loss of activity even under acidic conditions of
도 1은 본 발명의 실시예에서 사용된 인삼 뿌리, 인삼 잎, 인삼 꽃봉우리 및 인삼씨를 나타낸 것이다: 1: 인삼 뿌리, 2: 인삼 잎, 3: 인삼 꽃봉우리, 4: 인삼씨1 shows ginseng roots, ginseng leaves, ginseng buds and ginseng seeds used in Examples of the present invention: 1: ginseng root, 2: ginseng leaf, 3: ginseng bud, 4: ginseng seed
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 발명자들은 인삼 꽃봉오리를 대상으로 항균 효능을 검정하기 위하여, 일정 방법으로 인삼 꽃봉오리 추출물을 조제하고, 이를 항균 활성 성분으로 회수하였으며, 상기 추출물은 열 안정성과 산 안정성이 우수한 특징을 가짐을 확인함으로써 상기 인삼 꽃봉오리 추출물을 항균 조성물로 활용하고자 하였다. The inventors of the present invention prepared a ginseng bud extract by a certain method in order to test the antibacterial efficacy of ginseng buds, and recovered it as an antibacterial active ingredient, and the extract has excellent thermal stability and acid stability. By confirming the ginseng bud extract was intended to be used as an antibacterial composition.
특히, 상기 활성 추출물은 그람 양성 세균 및 그람 음성 세균 중 프로테우스 불가리스(Proteus vulgaris)에 대해 강력한 항균력을 나타내어, 다양한 세균 감염병에 대한 광범위 항균제 등으로 개발될 수 있음을 확인하여 본 발명을 완성하였다. In particular, the active extract showed a strong antibacterial activity against Proteus vulgaris among Gram-positive bacteria and Gram-negative bacteria, and confirmed that it can be developed as a broad-spectrum antibacterial agent for various bacterial infectious diseases, thereby completing the present invention.
구체적으로, 본 발명자들은 항암, 항염증, 간보호, 항고혈압 효과가 있다고 알려진 인삼 꽃봉오리를 이용하여 항균 조성물을 개발하기 위하여, 인삼 꽃봉오리를 대상으로 에탄올 추출물을 조제하고, 이의 다양한 세균 및 진균에 대한 항균력을 평가한 결과, 인삼 꽃봉오리 추출물에서는 그람 양성 세균에 대한 강력한 항균활성과, 그람 음성 세균 중 식중독세균으로 알려진 프로테우스 불가리스(Proteus vulgaris)에 대한 강력한 항균 활성을 나타내어, 상기 추출물이 광범위 항세균제로 이용 가능함을 확인하였다. Specifically, the present inventors prepared an ethanol extract for ginseng buds in order to develop an antibacterial composition using ginseng buds known to have anticancer, anti-inflammatory, hepatoprotective, and antihypertensive effects, and various bacteria and fungi thereof the evaluation of the antibacterial activity on, exhibits a strong antibacterial activity against the ginseng and a strong antibacterial activity against the bud extract of gram-positive bacteria, Gram-negative bacteria of the known food poisoning bacteria Proteus vulgaris (Proteus vulgaris), wherein the said extract broad It was confirmed that it can be used as a bacterial agent.
따라서, 본 발명은 인삼 꽃봉오리 추출물을 유효성분으로 함유하는 항균 조성물을 제공한다.Accordingly, the present invention provides an antibacterial composition containing a ginseng bud extract as an active ingredient.
상기 인삼 꽃봉오리 추출물은 물, 주정 및 탄소수 1~4의 무수 또는 함수 알코올로 이루어지는 군으로부터 선택된 용매로 추출되는 것이 바람직하며, 에탄올 추출이 가장 바람직하다.The ginseng bud extract is preferably extracted with a solvent selected from the group consisting of water, alcohol and anhydrous or hydrous alcohol having 1 to 4 carbon atoms, and ethanol extraction is most preferred.
상기 인삼 꽃봉오리 추출물은 헥센, 에틸아세테이트 및 부탄올의 유기용매로 순차 또는 각각 분획하여 헥센 분획물, 에틸아세테이트 분획물 및 부탄올 분획물 및 물 잔류물을 추가적으로 수득할 수도 있다.The ginseng bud extract may be fractionated sequentially or separately with an organic solvent of hexene, ethyl acetate and butanol to additionally obtain a hexene fraction, an ethyl acetate fraction, a butanol fraction, and a water residue.
또한, 상기 항균 조성물은 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품 첨가물, 화장품 첨가물, 동물 사료용 첨가물, 세정제 및 청결제로 이루어지는 군으로부터 선택되는 것이 바람직하다.In addition, the antimicrobial composition is preferably selected from the group consisting of pharmaceutical compositions, health functional foods, cosmetic compositions, animal feed compositions, food additives, cosmetic additives, additives for animal feed, detergents and cleaners.
이하에서는, 본 발명의 인삼 꽃봉오리 추출물의 제조 방법 및 효능 실험 등을 보다 구체적으로 설명한다.Hereinafter, the manufacturing method and efficacy experiments of the ginseng bud extract of the present invention will be described in more detail.
본 발명의 발명자들은 본 발명의 목적을 달성하기 위하여, 인삼 꽃봉오리 추출물을 조제하는 단계; 상기 추출물의 항균 활성 평가 단계; 및 인삼 꽃봉오리 추출물의 안정성 조사 단계를 수행하였다.The inventors of the present invention in order to achieve the object of the present invention, preparing a ginseng bud extract; Evaluating the antibacterial activity of the extract; and stability investigation of the ginseng bud extract.
본 발명의 조성물에 포함되는 "인삼 꽃봉오리 추출물"은 3~4년근 인삼의 꽃봉오리를 유기용매로 추출하는 단계 및 상기 추출액을 0.06mm 이하의 여과망을 사용하여 여과하고, 이를 감압농축하는 단계에 의해 수득될 수 있다.The "ginseng bud extract" contained in the composition of the present invention includes the steps of extracting the buds of 3- to 4-year-old ginseng with an organic solvent and filtering the extract using a filtration net of 0.06 mm or less, and concentrating it under reduced pressure. can be obtained by
본 발명에서 사용되는 용매는 물(냉수, 열수), 주정, 탄소수 1~4의 무수 또는 함수 저급 알코올(메탄올, 에탄올, 주정, 프로판올, 부탄올 등), 상기 저급 알코올과 물과의 혼합용매 등을 이용할 수 있으며, 열수, 또는 95% 에탄올 추출이 가장 바람직하다.The solvent used in the present invention is water (cold water, hot water), alcohol, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms (methanol, ethanol, alcohol, propanol, butanol, etc.), a mixed solvent of the lower alcohol and water, etc. hot water, or 95% ethanol extraction is most preferred.
바람직한 구체예로서, 본 발명의 인삼 꽃봉오리를 열수 또는 에탄올로 추출할 수 있다. 또한, 상기 열수 또는 에탄올 추출물은 헥센, 에틸아세테이트 및 부탄올의 유기용매로 순차 또는 각각 분획하여 헥센 분획물, 에틸아세테이트 분획물, 부탄올 분획물 및 물 잔류물을 추가적으로 수득할 수도 있다. As a preferred embodiment, the ginseng bud of the present invention may be extracted with hot water or ethanol. In addition, the hot water or ethanol extract may be fractionated sequentially or separately with an organic solvent of hexene, ethyl acetate and butanol to additionally obtain a hexene fraction, an ethyl acetate fraction, a butanol fraction and a water residue.
본 발명의 인삼 꽃봉오리 추출물은 감압건조 및 동결건조, 또는 분무건조 등과 같은 통상적인 분말화 과정을 거쳐 분말로 제조될 수 있다. 인삼 꽃봉오리 추출물은 혈장 내의 다양한 분해효소에 분해되지 않으며, 100℃의 열처리와 pH 2의 인체 위 내의 pH에서도 항균 활성을 유지한다.The ginseng bud extract of the present invention may be prepared as a powder through a conventional powdering process such as drying under reduced pressure, freeze drying, or spray drying. Ginseng bud extract is not degraded by various degrading enzymes in plasma, and it maintains antibacterial activity even at 100℃ heat treatment and
본 발명의 인삼 꽃봉오리 추출물은 강력한 항균 활성을 나타내어, 병원성 세균의 감염의 예방 또는 치료와 관련되는 약학 조성물, 건강 기능 식품, 화장료 조성물, 동물 사료 조성물, 식품, 화장품, 동물 사료용 첨가물 및 각종 청결제의 소재로 사용될 수 있다.The ginseng bud extract of the present invention exhibits strong antibacterial activity, and is used in pharmaceutical compositions, health functional foods, cosmetic compositions, animal feed compositions, food, cosmetics, additives for animal feed and various cleaners related to the prevention or treatment of pathogenic bacterial infections. material can be used.
바람직한 구체예로서, 본 발명의 항균 조성물은 약학적 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a pharmaceutical composition.
상기 약학적 조성물은 각각의 사용 목적에 맞게 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁제, 에멀젼, 시럽, 에어로졸 등의 경구 제형, 멸균 주사용액의 주사제 등 다양한 형태로 제형화하여 사용할 수 있으며, 경구 투여하거나 정맥 내, 복강 내, 피하, 직장, 국소 투여 등을 포함한 다양한 경로를 통해 투여될 수 있다. 이러한 약학적 조성물에는 추가적으로 담체, 부형제 또는 희석제 등이 더 포함될 수 있으며, 포함될 수 있는 적합한 담체, 부형제 또는 희석제의 예로는 락토오스, 덱스트로오스, 수크로오스, 솔비톨, 만니톨, 자일리톨, 에리쓰리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로스, 메틸 셀룰로스, 비정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등을 들 수 있다. 또한, 본 발명의 약학적 조성물은 충전제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 더 포함할 수도 있다. The pharmaceutical composition is formulated in various forms, such as oral formulations such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, and injections of sterile injection solutions, according to conventional methods for each purpose of use. It can be used, and it can be administered through various routes including oral administration or intravenous, intraperitoneal, subcutaneous, rectal, topical administration, and the like. The pharmaceutical composition may further include a carrier, excipient, or diluent, and examples of suitable carriers, excipients or diluents that may be included include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, Starch, gum acacia, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, amorphous cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil and the like. In addition, the pharmaceutical composition of the present invention may further include a filler, an anti-agglomeration agent, a lubricant, a wetting agent, a flavoring agent, an emulsifier, a preservative, and the like.
본 발명의 약학적 조성물은 약제학적으로 유효한 양으로 투여한다. 본 발명에서, "약제학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효 용량 수준은 환자의 질환의 종류, 중증도, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료 기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명의 약학적 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고, 종래의 치료제와 순차적으로 또는 동시에 투여될 수 있으며, 단일 또는 다중 투여될 수 있다. 상기한 요소들을 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 이는 당업자에 의해 용이하게 결정될 수 있다. The pharmaceutical composition of the present invention is administered in a pharmaceutically effective amount. In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit/risk ratio applicable to medical treatment, and the effective dose level is determined by the type, severity, activity of the drug, and the type of disease in the patient; Sensitivity to the drug, time of administration, route of administration and rate of excretion, duration of treatment, factors including concomitant drugs, and other factors well known in the medical field. The pharmaceutical composition of the present invention may be administered as an individual therapeutic agent or may be administered in combination with other therapeutic agents, may be administered sequentially or simultaneously with conventional therapeutic agents, and may be administered singly or multiple times. In consideration of all of the above factors, it is important to administer an amount that can obtain the maximum effect with a minimum amount without side effects, which can be easily determined by those skilled in the art.
본 발명의 약학적 조성물에서 항균 활성을 갖는 성분의 유효량은 환자의 나이, 성별, 체중에 따라 달라질 수 있으며, 일반적으로는 체중 당 1 내지 5,000mg, 바람직하게는 100 내지 3,000mg을 매일 또는 격일 투여하거나 1일 1 내지 3회로 나누어 투여할 수 있다. 그러나, 투여 경로, 질병의 중증도, 성별, 체중, 연령 등에 따라서 증감될 수 있으므로 상기 투여량이 어떠한 방법으로도 본 발명의 범위를 한정하는 것은 아니다. 본 발명의 약학적 조성물은 다양한 경로를 통하여 대상에 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관 내(intra-cerebroventricular) 주사에 의해 투여될 수 있다. 본 발명에서 "투여"는 임의의 적절한 방법으로 환자에게 소정의 물질을 제공하는 것을 의미하며, 본 발명의 약학적 조성물의 투여 경로는 목적 조직에 도달할 수 있는 한 일반적인 모든 경로를 통하여 경구 또는 비경구 투여될 수 있다. 또한, 본 발명의 조성물은 유효성분을 표적 세포로 전달할 수 있는 임의의 장치를 이용해 투여될 수도 있다. 본 발명에서 "대상"은, 특별히 한정되는 것은 아니지만, 예를 들어, 인간, 원숭이, 소, 말, 양, 돼지, 닭, 칠면조, 메추라기, 고양이, 개, 마우스, 쥐, 토끼 또는 기니아 피그를 포함하고, 바람직하게는 포유류, 보다 바람직하게는 인간을 의미한다. The effective amount of the component having antibacterial activity in the pharmaceutical composition of the present invention may vary depending on the age, sex, and weight of the patient, and generally 1 to 5,000 mg per body weight, preferably 100 to 3,000 mg per body weight, is administered daily or every other day Or it can be administered in divided
바람직한 구체예로서, 본 발명의 항균 조성물은 건강 기능 식품의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a dietary supplement.
본 발명의 건강 기능 식품은 병원성 미생물의 감염 우려가 높은 대상으로부터 감염의 가능성을 낮추어 줄 수 있는 효과적인 식품 및 음료 등에 다양하게 이용될 수 있다. 본 발명의 항균 활성이 우수한 유효성분을 포함하는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다. 본 발명의 활성 성분은 일반적으로 전체 식품 중량의 0.01 내지 15중량%로 가할 수 있으며, 건강음료 조성물은 100 ml를 기준으로 0.02 내지 10g, 바람직하게는 0.3 내지 1g의 비율로 가할 수 있다. 본 발명의 건강 기능 식품은 지시된 비율로 필수 성분으로서 상기 화합물을 함유하는 것 외에 식품학적으로 허용 가능한 식품보조 첨가제, 예컨대, 천연 탄수화물 및 다양한 향미제 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 예로는 포도당, 과당 등의 단당류, 말토오스, 수크로오스 등의 이당류 및 덱스트린, 시클로덱스트린 등의 다당류와 같은 통상적인 당 및 자일리톨, 소르비톨, 에리쓰리톨 등의 당알코올이 있다. 상기 향미제로는 타우마틴, 레바우디오시드 A, 글리시르히진, 사카린, 아스파르탐 등을 사용할 수 있다. 상기 향미제의 비율은 본 발명의 건강 기능 식품 100ml당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12g을 사용한다. 상기 외에 본 발명의 건강 기능 식품은 여러 가지 영양제, 비타민, 광물, 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강 기능 식품은 천연 과일 주스 및 과일 주스 음료 및 야채 음료 등의 제조를 위한 과육을 함유할 수도 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 본 발명의 상기 활성 분획물 100 중량부 당 0.01 내지 약 20중량부의 범위에서 선택되는 것이 일반적이다. The health functional food of the present invention can be used in various ways, such as effective foods and beverages that can lower the possibility of infection from a subject with a high risk of infection by pathogenic microorganisms. Foods containing the active ingredient having excellent antibacterial activity of the present invention include, for example, various foods, beverages, gum, tea, vitamin complexes, health supplements, and the like, in powder, granule, tablet, capsule or beverage form. can be used as In general, the active ingredient of the present invention may be added in 0.01 to 15% by weight of the total food weight, and the health beverage composition may be added in a proportion of 0.02 to 10 g, preferably 0.3 to 1 g, based on 100 ml. In addition to containing the above compound as an essential ingredient in the proportion indicated, the health functional food of the present invention may contain food pharmaceutically acceptable food supplement additives, such as natural carbohydrates and various flavoring agents, as additional ingredients. Examples of the natural carbohydrate include monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and conventional sugars such as polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, thaumatin, rebaudioside A, glycyrrhizin, saccharin, aspartame, and the like may be used. The ratio of the flavoring agent is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the health functional food of the present invention. In addition to the above, the health functional food of the present invention includes various nutrients, vitamins, minerals, flavoring agents such as synthetic and natural flavoring agents, colorants and thickeners, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloids It may contain thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonation agents used in carbonated beverages, and the like. In addition, the health functional food of the present invention may contain natural fruit juice, fruit juice for the production of fruit juice drinks, vegetable drinks, and the like. These components may be used independently or in combination. The proportion of these additives is generally selected in the range of 0.01 to about 20 parts by weight per 100 parts by weight of the active fraction of the present invention.
바람직한 구체예로서, 본 발명의 항균 조성물은 화장료 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as a cosmetic composition.
본 발명의 화장료 조성물은 본 발명의 항균 활성이 우수한 성분을, 예를 들어, 에센스, 영양크림, 바디로션, 린스, 샴푸, 바디클렌저, 로션, 스킨, 마스크팩 등의 형태로 제조될 수 있으며, 여기에 한정되는 것은 아니다. 상기 형태로의 제조는 당업자에게 알려진 다양한 제조 공정에 따라 용이하게 수행될 수 있을 것이다.The cosmetic composition of the present invention can be prepared in the form of, for example, essence, nourishing cream, body lotion, conditioner, shampoo, body cleanser, lotion, skin, mask pack, etc. It is not limited here. Preparation in the above form can be easily carried out according to various manufacturing processes known to those skilled in the art.
바람직한 구체예로서, 본 발명의 항균 조성물은 동물 사료 조성물의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as an animal feed composition.
상기 동물은 식물에 대응하는 생물군으로 주로 유기물을 영양분으로 섭취하며, 소화나 배성 및 호흡기관이 분화되어 있는 것을 말하고, 구체적으로는 극피동물, 갑각류, 연체동물, 어류, 양서류, 파충류, 조류, 포유류일 수 있으며, 바람직하게는 성게류 또는 해삼류와 같은 극피동물, 게, 새우, 대하 등의 갑각류를 포함하는 절지동물, 두족류, 복족류 또는 이매패류 등의 연체동물, 참돔, 도미, 대구, 가자미, 넙치 등의 어류, 꿩 또는 닭 등의 가금류를 포함하는 조류 또는 돼지, 소, 염소 등의 포유류일 수 있다.The animal is a group of organisms corresponding to plants, mainly ingesting organic matter as nutrients, and has differentiated digestive, embryonic and respiratory organs, specifically echinoderms, crustaceans, molluscs, fish, amphibians, reptiles, birds, may be mammals, preferably echinoderms such as sea urchins or sea cucumbers, arthropods including crustaceans such as crabs, shrimps and lobsters, molluscs such as cephalopods, gastropods or bivalves, red sea bream, sea bream, cod, flounder , fish such as halibut, birds including poultry such as pheasants or chickens, or mammals such as pigs, cattle, and goats.
상기 동물 사료용 조성물은 본 발명의 항균 성분을 포함하는 항균 조성물에 곡물, 식물성 단백질 사료, 동물성 단백질 사료, 당분 또는 유제품을 추가로 포함할 수 있다. 상기 곡물은 구체적으로는 분쇄 또는 파쇄된 밀, 귀리, 보리, 옥수수 및 쌀일 수 있고, 상기 식물성 단백질 사료는 구체적으로는 평지, 콩 및 해바라기를 주성분으로 하는 것일 수 있으며, 상기 동물성 단백질 사료는 구체적으로는 혈분, 육분, 골분 및 생선분일 수 있고, 상기 당분 또는 유제품은 구체적으로는 각종 분유 및 유장 분말로 이루어지는 건조성분일 수 있다.The composition for animal feed may further include grains, vegetable protein feed, animal protein feed, sugar or dairy products to the antimicrobial composition comprising the antimicrobial component of the present invention. The grain may be specifically pulverized or crushed wheat, oats, barley, corn and rice, and the vegetable protein feed may specifically include rapeseed, soybean and sunflower as main components, and the animal protein feed is specifically may be blood meal, meat meal, bone meal, and fish meal, and the sugar or dairy product may be a dry component consisting of various types of powdered milk and whey powder.
상기 동물 사료용 조성물은 추가로 영양 보충제, 소화 및 흡수 향상제, 성창 촉진제 또는 질병 예방제와 같은 성분을 함께 사용할 수 있다.The composition for animal feed may additionally contain ingredients such as nutritional supplements, digestion and absorption enhancers, vocal tract promoters or disease prevention agents.
본 발명의 동물 사료용 조성물에 포함되는 항균 조성물은 사료의 사용목적 및 사용조건에 따라 달라질 수 있으며, 일 예로 최종 생산된 사료 1kg을 기준으로 상기 항균성 조성물이 0.1g 내지 100g 포함될 수 있다.The antimicrobial composition included in the composition for animal feed of the present invention may vary depending on the purpose and conditions of use of the feed, for example, 0.1 g to 100 g of the antimicrobial composition may be included based on 1 kg of the finally produced feed.
또한, 상기 사료 조성물은 성분들의 분쇄 정도에 따라 경점성의 조립 또는 과립 물질로 제조될 수 있으며, 상기 조성물은 메쉬로 공급되거나 추가 가공 및 포장을 위해 원하는 분리된 형상으로 형성시킬 수 있으며, 저장을 위해 펠렛화, 팽창화 또는 압출 공정을 거칠 수 있으며, 저장의 용이성을 위해 바람직하게는 과잉의 물을 건조 제거될 수 있다.In addition, the feed composition may be prepared as a hard viscous granulated or granular material depending on the degree of pulverization of the ingredients, and the composition may be supplied as a mesh or formed into a desired separated shape for further processing and packaging, and storage For ease of storage, it may be subjected to pelletization, expansion or extrusion process, and preferably excess water may be removed by drying.
바람직한 구체예로서, 본 발명의 항균 조성물은 식품, 화장품 또는 동물 사료용 첨가제의 용도로서 적용될 수 있다. In a preferred embodiment, the antimicrobial composition of the present invention can be applied as an additive for food, cosmetics or animal feed.
상기 첨가제는 사용되는 식품, 화장품 또는 동물 사료에 보존성을 부여하기 위하여 첨가되는 것으로서, 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로 식품, 화장품 또는 동물용 사료에 안전하게 적용할 수 있다.The additive is added to impart preservation to the food, cosmetic or animal feed used, and the antibacterial composition is a natural ingredient and is not harmful to the human body, so it can be safely applied to food, cosmetics or animal feed.
상기 첨가제는 그 사용 목적 및 용도에 따라 적의 선택된 추가적인 여타의 첨가물을 추가로 더 포함할 수 있으며, 통상적으로 사용되는 첨가물 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가물과 혼합하여 사용할 수 있다. 상기 첨가제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으며, 제품화를 위하여 포장을 위해 통상의 방법을 사용할 수 있다.The additive may further include additional other additives appropriately selected according to the purpose and purpose of use, and may be used by mixing with other active ingredients such as commonly used additives or additives such as pigments, surfactants, and preservatives. . The additive may be manufactured by powdering, granulating, tableting or liquefying according to the purpose and use thereof, and a conventional method for packaging may be used for productization.
또한, 상기 첨가제 중 항균 조성물의 사용량은 사용목적과 적용형태, 적용부위, 적용대상물품 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.In addition, the amount of the antimicrobial composition used among the additives may be appropriately used depending on the purpose of use, application form, application site, application target article, etc., for example, it may include 0.01 parts by weight to 50 parts by weight based on the total composition, but The content of the composition is not limited thereto. Since the antibacterial composition of the present invention is a natural component and is not harmful to the human body, it can be used in various amounts as long as the application purpose can be achieved due to the characteristics of the product.
바람직한 구체예로서, 본 발명은 항균 조성물은 세정제의 용도로서 적용될 수 있다.In a preferred embodiment, the present invention can be applied as an antibacterial composition for use as a cleaning agent.
상기 세정제는 바람직하게는 의류용 세제, 식기 세척제, 식품 세정제, 가전제품 세척제일 수 있다. 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 더욱 바람직하게는 주방용품 또는 식품세척 등을 포함하는 각종 생활용품의 세척이나 항균성 부여를 목적으로 사용할 수 있다.The cleaning agent may be preferably a detergent for clothes, a dishwashing agent, a food cleaner, and a household appliance cleaner. Since the antibacterial composition is a natural component, it is not harmful to the human body, and more preferably, it can be used for the purpose of washing various household items including kitchenware or food washing or for imparting antibacterial properties.
상기 세정제는 그 사용 목적 및 용도에 따라 적의 선택된 첨가물을 추가로 포함할 수 있으며, 통상적으로 사용되는 세정제 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가제와 혼합하여 사용할 수 있다. 상기 세정제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으며, 제품화를 위하여 포장을 위해 통상의 방법을 사용할 수 있다.The detergent may further include an additive selected appropriately according to the purpose and purpose of its use, and may be used by mixing with other active ingredients such as commonly used detergents or additives such as pigments, surfactants, and preservatives. The detergent may be prepared by powdering, granulating, tableting or liquefying according to the purpose and use thereof, and a conventional method for packaging may be used for productization.
또한, 상기 세정제 중 항균성 조성물의 사용량은 사용목적과 적용형태, 적용부위, 적용대상물품 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균성 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균성 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.In addition, the amount of the antimicrobial composition used in the cleaning agent may be appropriately used depending on the purpose of use, application form, application site, application target article, etc., and may include, for example, 0.01 parts by weight to 50 parts by weight based on the total composition, but The content of the composition is not limited thereto. Since the antimicrobial composition of the present invention is a natural component and is not harmful to the human body, it can be used in various amounts if the application purpose can be achieved due to the characteristics of the product.
바람직한 구체예로서, 본 발명은 항균 조성물은 청결제의 용도로서 적용될 수 있다.In a preferred embodiment, the present invention can be applied as an antibacterial composition for use as a cleaning agent.
상기 청결제는 일상 생활에서 흔히 감염되기 쉬운 병원성 미생물의 체내 감염을 예방 차원에서 수행하기 위하여 간단한 방법으로 손, 구강 또는 여성용 청결제 등의 용도로 사용될 수 있다. 상기 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로 손, 구강, 여성용 청결제로 사용하는 경우에도 안전하게 적용할 수 있다.The cleanser may be used as a hand, oral or feminine cleanser in a simple way in order to prevent infection of pathogenic microorganisms that are easily infected in daily life in a simple way. Since the antibacterial composition is a natural component and is not harmful to the human body, it can be safely applied even when used as a hand, oral, and feminine cleanser.
상기 청결제는 그 사용 목적 및 용도에 따라 적의 선택된 추가적인 여타의 첨가물을 추가로 더 포함할 수 있으며, 통상적으로 사용되는 첨가물 등 다른 유효성분이나 색소, 계면활성제, 방부제 등의 첨가물과 혼합하여 사용할 수 있다. 상기 청결제는 그 사용 목적 및 용도에 따라 분말화, 과립화, 정제화 또는 액상화하여 제조될 수 있으나, 액상형의 경우 편리한 사용이 가능할 것이다.The cleaning agent may further include additional additives appropriately selected according to the purpose and purpose of use, and may be used by mixing with other active ingredients such as commonly used additives or additives such as pigments, surfactants, and preservatives. . The cleaning agent may be manufactured by powdering, granulating, tableting, or liquefying depending on the purpose and use thereof, but in the case of a liquid type, convenient use will be possible.
또한, 상기 청결제 중 항균 조성물의 사용량은 사용목적과 적용형태, 적용부위 등에 따라 적절히 사용될 수 있으며, 예를 들면 전체 조성물 기준으로 0.01 중량부 내지 50 중량부를 포함할 수 있으나, 상기 항균 조성물의 함량은 이에 한정되는 것은 아니다. 본원 발명의 항균 조성물은 천연성분으로 인체에 유해하지 아니하므로, 그 제품의 특성상 적용목적을 달성할 수 있는 경우라면 다양한 양으로 사용가능하다.In addition, the amount of the antibacterial composition used in the cleaning agent may be appropriately used depending on the purpose of use, application form, application site, etc., for example, it may include 0.01 parts by weight to 50 parts by weight based on the total composition, but the content of the antibacterial composition is The present invention is not limited thereto. Since the antibacterial composition of the present invention is a natural component and is not harmful to the human body, it can be used in various amounts as long as the application purpose can be achieved due to the characteristics of the product.
이하에서는 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 하기 실시예는 본 발명의 바람직한 일 구체예일 뿐이며, 본 발명의 권리범위가 하기 실시예의 범위로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. The following examples are only preferred embodiments of the present invention, and the scope of the present invention is not limited to the scope of the following examples.
[실시예][Example]
실시예 1: 인삼 부위별 추출물의 조제 및 이들의 유용성분 분석 Example 1: Preparation of extracts for each part of ginseng and analysis of their useful components
2018년 경북 영주에서 4년근 인삼의 뿌리, 잎, 꽃봉오리를 채취하고, 이를 통상의 방법으로 열풍건조(60℃)한 후 사용하였다. 인삼 열매는 7월에 채종하였으며 채취한 종자를 망사자루에 넣고, 흐르는 물에 담가 하루정도 불린 다음 손으로 문질러 과육을 완전히 제거한 후 1일간 음건하여 사용하였다(도 1). 각각의 인삼부위는 조분쇄한 후 에탄올(95%) 추출하였으며, 시료 무게에 대해 10배의 에탄올을 가하고 상온에서 3회 반복 추출한 후 추출액을 모아 필터링한 후, 감압 농축하여 분말로 제조하여 에탄올 추출물을 제조하였다. 한편, 인삼씨 에탄올 추출물은 감압 농축시 상층의 오일부분과 하층의 침전물 부분으로 구분되어 이들을 각각 회수하였다. 또한 상기의 인삼씨는 기계착유하여 별도로 인삼씨 오일을 회수하였다. In 2018, the roots, leaves, and flower buds of 4-year-old ginseng were collected in Yeongju, Gyeongbuk, and dried with hot air (60° C.) in the usual way before use. The ginseng fruit was harvested in July, and the collected seeds were put in a mesh bag, soaked in running water for about a day, then rubbed with hands to completely remove the pulp, and then dried in the shade for 1 day (FIG. 1). Each ginseng part was coarsely pulverized and extracted with ethanol (95%), 10 times the weight of the sample was added with ethanol, extracted three times at room temperature, the extract was collected, filtered, and concentrated under reduced pressure to make a powder, and the ethanol extract was prepared. On the other hand, the ethanol extract of ginseng seed was divided into an upper oil part and a lower layer sediment part during concentration under reduced pressure, and these were recovered respectively. In addition, the above ginseng seeds were machine milked to separately recover ginseng seed oil.
[표 1] 인삼 부위별로부터 얻어진 추출물, 착유오일의 회수율[Table 1] Recovery rate of extracts and milking oil obtained from each part of ginseng
인삼 각각의 부위에 대한 에탄올 추출물의 회수율은, 표 1에 나타낸 바와 같이, 씨(8.4%) > 잎(4.3%) > 꽃봉우리(1.3%) > 뿌리(0.3%) 순으로 나타났으며, 인삼씨의 기계착유의 경우 회수율은 약 5%로 나타났다. 인삼씨 기계착유 오일은 암갈색의 오일이었으나, 인삼씨 에탄올 추출물을 감압농축한 후 상층에 생성되는 오일은 밝은 황색을 나타내었다. 인삼 꽃봉오리 추출물은 인삼 꽃봉오리 100g에 대해 약 1.3g을 회수할 수 있었으며, 인삼꽃 특유의 매운 맛은 거의 나타나지 않았다. The recovery rate of the ethanol extract for each part of ginseng, as shown in Table 1, was in the order of seeds (8.4%) > leaves (4.3%) > flower buds (1.3%) > roots (0.3%), and ginseng In the case of machine milking of seeds, the recovery rate was about 5%. The ginseng seed mechanically extracted oil was dark brown oil, but the oil produced in the upper layer after concentration of the ethanol extract of ginseng seed under reduced pressure showed a bright yellow color. About 1.3 g of ginseng bud extract could be recovered for 100 g of ginseng flower bud, and the characteristic pungent taste of ginseng flower hardly appeared.
실시예 2: 인삼 부위별로부터 얻어진 추출물 및 오일들의 유용성분 분석Example 2: Analysis of useful components of extracts and oils obtained from each part of ginseng
실시예 1에서 얻어진 시료들을 대상으로 총 폴리페놀, 총 플라보노이드, 총 당 및 환원당 함량을 측정하였다. 총 폴리페놀 함량은 추출 검액 400μl에 50μl의 Folin-ciocalteau, 100μl의 Na2CO3 포화용액을 넣고, 실온에서 1시간 방치한 후 725nm에서 흡광도를 측정하였다. 표준시약으로는 tannic acid를 사용하였다. 총 플라보노이드 함량은 각각의 시료를 18시간 메탄올 교반 추출하고, 여과한 추출 검액 400μl에 90% diethylene glycol 4ml를 첨가하고 다시 1 N NaOH 40μl를 넣고, 37℃에서 1시간 반응 후 420nm에서 흡광도를 측정하였다. 표준시약으로는 rutin을 사용하였다. 환원당은 DNS법으로, 총 당은 phenol-sulfuric acid법을 이용하여 정량하였다. Total polyphenols, total flavonoids, total sugars and reducing sugar contents were measured for the samples obtained in Example 1. For the total polyphenol content, 50 μl of Folin-ciocalteau and 100 μl of Na 2 CO 3 saturated solution were added to 400 μl of the extraction sample solution, and the absorbance was measured at 725 nm after standing at room temperature for 1 hour. As a standard reagent, tannic acid was used. For the total flavonoid content, each sample was extracted with methanol for 18 hours, and 4 ml of 90% diethylene glycol was added to 400 μl of the filtered extraction sample, 40 μl of 1 N NaOH was added again, and the absorbance was measured at 420 nm after reaction at 37° C. for 1 hour. . As a standard reagent, rutin was used. Reducing sugar was quantified by DNS method and total sugar was quantified by phenol-sulfuric acid method.
[표 2] 인삼 부위별 추출물 및 오일들의 유용성분 분석[Table 2] Analysis of useful components of extracts and oils for each part of ginseng
표 2에 나타낸 바와 같이, 인삼의 다양한 부위별 추출물 및 오일의 유용성분 분석 결과, 총 폴리페놀 함량은 인삼잎 추출물에서 가장 높은 22.5mg/g의 함량을 보였으며, 잎 추출물 > 꽃봉오리 추출물 > 뿌리 추출물 ≒ 씨 추출물의 침전물 > 씨 추출물의 상층 오일 > 씨 착유오일 순으로 나타났다. 총 플라보노이드 함량 측정 결과 역시 인삼잎 추출물에서 가장 높은 13.4mg/g을 보였으며, 잎 추출물 > 꽃봉오리 추출물 > 뿌리 추출물 > 씨 추출물의 침전물 > 씨 추출물의 상층 오일 ≒ 씨 착유오일 순으로 나타났다. 총 당 및 환원당 함량의 경우에는 잎 추출물 > 꽃봉오리 추출물 > 씨 추출물의 침전물 > 뿌리 추출물 > 씨 추출물의 상층 오일 ≒ 씨 착유오일 순으로 나타났다. 이러한 결과는 특별한 용도 없이 폐기되고 있는 인삼 잎 및 꽃봉오리를 이용한 기능성 소재 개발이 가능함을 보여주고 있다. As shown in Table 2, as a result of analysis of the useful components of extracts and oils by various parts of ginseng, the total polyphenol content was the highest in the ginseng leaf extract at 22.5 mg/g, leaf extract > bud extract > root Extract ≒ sediment of seed extract > supernatant oil of seed extract > seed milking oil. As a result of measuring the total flavonoid content, ginseng leaf extract showed the highest 13.4 mg/g, and leaf extract > flower bud extract > root extract > seed extract sediment > seed extract upper oil ≒ seed milking oil. In the case of total sugar and reducing sugar content, leaf extract > bud extract > sediment of seed extract > root extract > oil of the upper layer of seed extract ≒ seed milking oil was shown in the following order. These results show that it is possible to develop functional materials using ginseng leaves and flower buds that are discarded without any special use.
실시예 3: 인삼 부위별 추출물 및 오일들의 항균 활성 평가 Example 3: Evaluation of antibacterial activity of extracts and oils for each part of ginseng
실시예 1에서 제조된 인삼 추출물 및 오일들의 항균 활성을 평가하였으며, 그 결과를 표 3에 나타내었다. 항균 활성 평가에 사용된 균주로는, 그람 음성균으로서 Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433, Pseudomonas aeruginosa KACC 10186, Salmonella typhimurium KCTC 1926을 사용하였고, 그람 양성균으로는 Staphylococcus aureus KCTC 1916, Staphylococcus epidermidis ATCC 12228, Listeria monocytogenes KACC 10550, Bacillus subtilis KCTC 1924를 사용하였다. 한편, 항진균 활성 평가를 위해서는 Saccharomyces cerevisiae IF0 0233 및 캔디다증 진균감염증 원인균 Candida albicans KCTC 1940을 사용하였다. The antibacterial activity of the ginseng extract and oils prepared in Example 1 was evaluated, and the results are shown in Table 3. As strains used for the evaluation of antibacterial activity, Escherichia coli KCTC 1682, Proteus vulgaris KCTC 2433, Pseudomonas aeruginosa KACC 10186, Salmonella typhimurium KCTC 1926 were used as Gram-negative bacteria, and Staphylococcus aureus KCTC 1916, Staphylococcus epidermidis ATCC 12228, Staphylococcus epidermidis were used as Gram-positive bacteria. Listeria monocytogenes KACC 10550 and Bacillus subtilis KCTC 1924 were used. Meanwhile, for the evaluation of antifungal activity, Saccharomyces cerevisiae IF0 0233 and Candida albicans KCTC 1940, a causative agent of Candida fungal infection, were used.
먼저, 항세균 활성 평가의 경우, Nutrient broth(Difco Co., USA)에 각각의 세균을 접종하여 37℃에서 24시간 동안 배양한 후, 각 균주를 O.D.600 0.1로 조정하여 Nutrient agar(Difco Co., USA) 배지를 포함하는 멸균 petri dish(90mm, 녹십자, 한국)에 100μl씩 도말하고, 각각의 시료 5μl를 멸균 disc-paper(지름 6.5mm, Whatsman No. 2)에 가하여, 37℃에서 24시간 동안 배양하였으며, 진균의 경우에는, Sabouraud dextrose(Difco Co. USA)를 이용하여 동일한 방법으로 30℃에서 24시간 동안 배양 후, 생육저지환의 크기를 측정하여 항균활성을 평가하였다. 대조구로는 항세균제인 엠피실린(ampicillin)과 항진균제인 마이코나졸(miconazole, Sigma Co., USA)을 각각 1μg/disc 농도로 사용하였으며, 생육저지환의 크기는 육안으로 생육이 나타나지 않는 부분의 지름을 mm 단위로 측정하였고, 3회 이상 평가 후 대표 결과로 나타내었다.First, in the case of antibacterial activity evaluation, each bacteria was inoculated in Nutrient broth (Difco Co., USA) and cultured at 37° C. for 24 hours, and then each strain was adjusted to OD 600 0.1 to Nutrient agar (Difco Co. , USA) 100 μl of each sample is smeared on a sterile petri dish (90 mm, Green Cross, Korea) containing the medium, and 5 μl of each sample is added to sterile disc-paper (diameter 6.5 mm, Whatsman No. 2), at 37° C. for 24 hours. In the case of fungi, the antibacterial activity was evaluated by measuring the size of the growth inhibition ring after incubation for 24 hours at 30°C in the same manner using Sabouraud dextrose (Difco Co. USA). As a control, the antibacterial ampicillin and the antifungal myconazole (miconazole, Sigma Co., USA) were each used at a concentration of 1 μg/disc. It was measured in mm, and after evaluation three or more times, it is shown as a representative result.
[표 3] 인삼 부위별 추출물 및 오일들의 항균 활성[Table 3] Antibacterial activity of extracts and oils for each part of ginseng
그 결과, 표 3에 나타낸 바와 같이, 임상에서 항세균제로 사용되고 있는 ampicillin 은 1μg/disc에서도 광범위한 항균 활성을 나타내었으며, Pseudomonas aeruginosa 및 Salmonella typhimurium에 대해서는 상대적으로 약한 생육억제환(9~15mm)을 나타내었다. 임상에서 항진균제로 사용되고 있는 miconazole 은 1μg/disc에서도 Saccharomyces cerevisiae와 Candida albicans의 생육을 강하게 저해하였다. 한편, 인삼 꽃봉오리 추출물은 500μg/disc 농도에서 그람 양성균인 Listeria monocytogenes, Bacillus subtilis, Staphylococcus epidermidis, Staphylococcus aureus 및 그람 음성균인 Proteus vulgaris에 대한 우수한 생육억제를 나타내었다. As a result, as shown in Table 3, ampicillin, which is used as an antibacterial agent in clinical practice, showed a wide range of antibacterial activity even at 1 μg/disc, and showed relatively weak growth inhibitory rings (9-15 mm) against Pseudomonas aeruginosa and Salmonella typhimurium. It was. Miconazole, used as an antifungal agent in clinical practice, strongly inhibited the growth of Saccharomyces cerevisiae and Candida albicans even at 1 μg/disc. On the other hand, the ginseng bud extract showed excellent growth inhibition against gram-positive bacteria Listeria monocytogenes , Bacillus subtilis , Staphylococcus epidermidis , Staphylococcus aureus and gram-negative bacteria Proteus vulgaris at a concentration of 500 μg/disc.
실시예 4: 인삼 꽃봉오리 추출물의 혈장, 산 및 열 안정성 평가Example 4: Evaluation of Plasma, Acid and Thermal Stability of Ginseng Bud Extract
상기 실시예 1에서 얻은 인삼 꽃봉오리 에탄올 추출물을 대상으로 항균 활성에 대한 혈장 안정성, 열 안정성 및 산 안정성을 확인하였다. 그 결과, 상기 활성 추출물은 100℃에서 1시간 열 처리, pH 2(0.01M HCl)에서의 1시간 처리, 혈장에서 1시간 처리시에도 항균 활성의 심각한 손실이 나타나지 않아 높은 안정성을 나타내었다. 따라서, 상기의 인삼 꽃봉오리 에탄올 추출물은 다양한 식품 가공 공정하에서도 우수한 항균 활성을 유지할 것으로 예상된다.Plasma stability, thermal stability and acid stability for antibacterial activity were confirmed for the ethanol extract of ginseng bud obtained in Example 1. As a result, the active extract showed no significant loss of antibacterial activity even after 1 hour heat treatment at 100° C., 1 hour treatment at pH 2 (0.01M HCl), and 1 hour treatment in plasma. Therefore, the ethanol extract of ginseng bud is expected to maintain excellent antibacterial activity even under various food processing processes.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190081667A KR102287389B1 (en) | 2019-07-06 | 2019-07-06 | Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190081667A KR102287389B1 (en) | 2019-07-06 | 2019-07-06 | Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210005459A KR20210005459A (en) | 2021-01-14 |
KR102287389B1 true KR102287389B1 (en) | 2021-08-06 |
Family
ID=74142117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190081667A KR102287389B1 (en) | 2019-07-06 | 2019-07-06 | Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102287389B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018139809A1 (en) * | 2017-01-26 | 2018-08-02 | (주)아모레퍼시픽 | Composition containing, as active ingredient, ginseng flower extract having increased amount of ginsenosides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101082277B1 (en) * | 2006-11-17 | 2011-11-09 | 박용진 | Composition comprising an extract of flower bud o f black ginseng showing anti-oxidative activity |
KR101082173B1 (en) * | 2006-11-17 | 2011-11-09 | 박용진 | A method for preparation of flower bud of black ginseng and a composition comprising the extract thereof showing anti-aging activity |
KR101374351B1 (en) * | 2012-01-31 | 2014-03-19 | 주식회사 씨오투바이오 | A composition comprising the dried flower bud powder of Black Panax ginseng for treating and preventing atopic disease |
-
2019
- 2019-07-06 KR KR1020190081667A patent/KR102287389B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018139809A1 (en) * | 2017-01-26 | 2018-08-02 | (주)아모레퍼시픽 | Composition containing, as active ingredient, ginseng flower extract having increased amount of ginsenosides |
Non-Patent Citations (2)
Title |
---|
International Journal of Food Science&Technology 2013, 48, pp.947-953 |
J. Soc. Cosmet. Scientists Korea, Vol.34, No.1, March 2008, pp.67-73 |
Also Published As
Publication number | Publication date |
---|---|
KR20210005459A (en) | 2021-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101715622B1 (en) | Antimicrobial composition comprising the extraction of suaeda spp as an effective component | |
KR20200003993A (en) | Antimicrobial composition comprising the leaf extract of polygonium ticnctorium and use thereof | |
KR102243591B1 (en) | Antimicrobial composition comprising the extract of rodgersia podophylla | |
KR102086166B1 (en) | Antimicrobial composition comprising the extracts of rambutan peel | |
KR20170072052A (en) | An antibacterial composition comprising the pachyrhizus erosus root bark extract as an effective component | |
KR101602552B1 (en) | Antimicrobial composition comprising the extract of cornus officinalis | |
KR101976201B1 (en) | Antimicrobial composition comprising the sprout extract of zingiber officinale | |
KR102254420B1 (en) | Antimicrobial composition comprising the fermentation extract of medicinal or edible natural products | |
KR102254424B1 (en) | Antimicrobial composition comprising the extract of sageretia thea | |
KR101911847B1 (en) | Antimicrobial composition comprising organic solvent fractions of arctium lappa root extracts as an effective component | |
KR102287389B1 (en) | Antimicrobial composition comprising the extract of flower bud of panax ginseng c. a. meyer | |
KR102669103B1 (en) | Antimicrobial composition comprising the micro scaled powder of bast fiber of cannabis sativa l. | |
KR102481102B1 (en) | Antibacterial composition containing starfish extract and cinnamon extract as active ingredients | |
KR102287391B1 (en) | Antimicrobial composition comprising the extract of moringa root | |
KR102254425B1 (en) | Antimicrobial composition comprising the extract of immature fruit extract of magnolia denudata | |
KR20220094308A (en) | Pharmaceutical composition for preventing or treating infectious symptoms by pathogenic microorganism comprising Cichorium intybus extract as an active ingredient | |
KR102534868B1 (en) | Antimicrobial composition comprising the extract from coccon of protaetia brevitarsis | |
KR102677601B1 (en) | Antimicrobial composition comprising the kenaf seed extract of jang-dae cultivar | |
KR20200058353A (en) | Antimicrobial composition comprising the hexane and butanol fractions of teleogryllus emma extract | |
KR102572181B1 (en) | Antimicrobial composition comprising the extract from wasp | |
KR102131454B1 (en) | Antimicrobial composition comprising the extract of yunnongchamssal | |
KR102428964B1 (en) | Antimicrobial composition comprising the extracts of hermetia illucens | |
KR102074558B1 (en) | ANTIBACTERAL COMPOSITION AGAINST PATHOGENIC BACTERIA COMPRISING EXTRACT OF Forsythia suspensa | |
KR20200113919A (en) | Antimicrobial composition comprising the extract of loranthus yadoriki | |
KR20240021683A (en) | Antimicrobial composition comprising the extracts of pollen of cannabis sativa l. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |